Literature DB >> 27454028

New insights in the development of pancreatic cancer.

Smrita Sinha1, Steven D Leach.   

Abstract

PURPOSE OF REVIEW: The review intends to describe recent studies on the development of pancreatic cancer from a genetic, molecular, and microenvironment perspective. RECENT
FINDINGS: Pancreatic cancer has been discovered to have distinct molecular subtypes based on transcriptome analyses that may have implications for treatment. Recent studies are also mapping the complex molecular biology of this cancer as it relates to the core signaling abnormalities inherent to this disease. There have been discoveries of novel modes of regulation of pancreatic cancer development, including alterations in key transcription factors, epigenetic modifiers, and metabolic pathways. Studies of the tumor-associated microenvironment continue to reveal its complex role in tumor development.
SUMMARY: Pancreatic cancer development appears to depend on a multifaceted network of signals that are dynamic, involve multiple cell types, and are linked to spatiotemporal factors in tumor evolution. Understanding the development of pancreatic cancer in this context is key to identifying novel and effective targets for treatment.

Entities:  

Year:  2016        PMID: 27454028      PMCID: PMC6028298          DOI: 10.1097/MOG.0000000000000295

Source DB:  PubMed          Journal:  Curr Opin Gastroenterol        ISSN: 0267-1379            Impact factor:   3.287


  49 in total

1.  Genome-wide analysis of promoter methylation associated with gene expression profile in pancreatic adenocarcinoma.

Authors:  Audrey Vincent; Noriyuki Omura; Seung-Mo Hong; Andrew Jaffe; James Eshleman; Michael Goggins
Journal:  Clin Cancer Res       Date:  2011-05-24       Impact factor: 12.531

2.  Stat3/Socs3 activation by IL-6 transsignaling promotes progression of pancreatic intraepithelial neoplasia and development of pancreatic cancer.

Authors:  Marina Lesina; Magdalena U Kurkowski; Katharina Ludes; Stefan Rose-John; Matthias Treiber; Günter Klöppel; Akihiko Yoshimura; Wolfgang Reindl; Bence Sipos; Shizuo Akira; Roland M Schmid; Hana Algül
Journal:  Cancer Cell       Date:  2011-04-12       Impact factor: 31.743

3.  Aberrant methylation of preproenkephalin and p16 genes in pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma.

Authors:  Noriyoshi Fukushima; Norihiro Sato; Takashi Ueki; Christophe Rosty; Kimberly M Walter; Robb E Wilentz; Charles J Yeo; Ralph H Hruban; Michael Goggins
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

Review 4.  KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma.

Authors:  John P Morris; Sam C Wang; Matthias Hebrok
Journal:  Nat Rev Cancer       Date:  2010-09-03       Impact factor: 60.716

5.  Aberrant methylation of the 5' CpG island of TSLC1 is common in pancreatic ductal adenocarcinoma and is first manifest in high-grade PanlNs.

Authors:  Marnix Jansen; Noriyoshi Fukushima; Christophe Rosty; Kim Walter; Renee Altink; Tjarda Van Heek; Ralph Hruban; Johan G Offerhaus; Michael Goggins
Journal:  Cancer Biol Ther       Date:  2002 May-Jun       Impact factor: 4.742

6.  Pancreatic cancers require autophagy for tumor growth.

Authors:  Shenghong Yang; Xiaoxu Wang; Gianmarco Contino; Marc Liesa; Ergun Sahin; Haoqiang Ying; Alexandra Bause; Yinghua Li; Jayne M Stommel; Giacomo Dell'antonio; Josef Mautner; Giovanni Tonon; Marcia Haigis; Orian S Shirihai; Claudio Doglioni; Nabeel Bardeesy; Alec C Kimmelman
Journal:  Genes Dev       Date:  2011-03-15       Impact factor: 11.361

7.  Oncogenic Kras-induced GM-CSF production promotes the development of pancreatic neoplasia.

Authors:  Yuliya Pylayeva-Gupta; Kyoung Eun Lee; Cristina H Hajdu; George Miller; Dafna Bar-Sagi
Journal:  Cancer Cell       Date:  2012-06-12       Impact factor: 31.743

8.  Identification of Sox9-dependent acinar-to-ductal reprogramming as the principal mechanism for initiation of pancreatic ductal adenocarcinoma.

Authors:  Janel L Kopp; Guido von Figura; Erin Mayes; Fen-Fen Liu; Claire L Dubois; John P Morris; Fong Cheng Pan; Haruhiko Akiyama; Christopher V E Wright; Kristin Jensen; Matthias Hebrok; Maike Sander
Journal:  Cancer Cell       Date:  2012-11-29       Impact factor: 31.743

9.  Core signaling pathways in human pancreatic cancers revealed by global genomic analyses.

Authors:  Siân Jones; Xiaosong Zhang; D Williams Parsons; Jimmy Cheng-Ho Lin; Rebecca J Leary; Philipp Angenendt; Parminder Mankoo; Hannah Carter; Hirohiko Kamiyama; Antonio Jimeno; Seung-Mo Hong; Baojin Fu; Ming-Tseh Lin; Eric S Calhoun; Mihoko Kamiyama; Kimberly Walter; Tatiana Nikolskaya; Yuri Nikolsky; James Hartigan; Douglas R Smith; Manuel Hidalgo; Steven D Leach; Alison P Klein; Elizabeth M Jaffee; Michael Goggins; Anirban Maitra; Christine Iacobuzio-Donahue; James R Eshleman; Scott E Kern; Ralph H Hruban; Rachel Karchin; Nickolas Papadopoulos; Giovanni Parmigiani; Bert Vogelstein; Victor E Velculescu; Kenneth W Kinzler
Journal:  Science       Date:  2008-09-04       Impact factor: 47.728

10.  Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy.

Authors:  Eric A Collisson; Anguraj Sadanandam; Peter Olson; William J Gibb; Morgan Truitt; Shenda Gu; Janine Cooc; Jennifer Weinkle; Grace E Kim; Lakshmi Jakkula; Heidi S Feiler; Andrew H Ko; Adam B Olshen; Kathleen L Danenberg; Margaret A Tempero; Paul T Spellman; Douglas Hanahan; Joe W Gray
Journal:  Nat Med       Date:  2011-04-03       Impact factor: 53.440

View more
  6 in total

1.  Dendritic cell immunotherapy induces anti-tumor effect in a transgenic mouse model of pancreatic ductal adenocarcinoma.

Authors:  Jia Yang; Su Hu; Junjie Shangguan; Aydin Eresen; Yu Li; Liang Pan; Quanhong Ma; Yuri Velichko; Jian Wang; Chunhong Hu; Vahid Yaghmai; Zhuoli Zhang
Journal:  Am J Cancer Res       Date:  2019-11-01       Impact factor: 6.166

2.  PanIN Neuroendocrine Cells Promote Tumorigenesis via Neuronal Cross-talk.

Authors:  Smrita Sinha; Ya-Yuan Fu; Adrien Grimont; Maren Ketcham; Kelly Lafaro; Joseph A Saglimbeni; Gokce Askan; Jennifer M Bailey; Jerry P Melchor; Yi Zhong; Min Geol Joo; Olivera Grbovic-Huezo; In-Hong Yang; Olca Basturk; Lindsey Baker; Young Park; Robert C Kurtz; David Tuveson; Steven D Leach; Pankaj J Pasricha
Journal:  Cancer Res       Date:  2017-04-06       Impact factor: 12.701

3.  Overcoming Therapeutic Challenges for Pancreatic Ductal Adenocarcinoma with xCT Inhibitors.

Authors:  Milica Vucetic; Boutaina Daher; Shamir Cassim; Scott Parks; Jacques Pouyssegur
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Commonly Used Pancreatic Stellate Cell Cultures Differ Phenotypically and in Their Interactions with Pancreatic Cancer Cells.

Authors:  Daniela Lenggenhager; Manoj Amrutkar; Petra Sántha; Monica Aasrum; Johannes-Matthias Löhr; Ivar P Gladhaug; Caroline S Verbeke
Journal:  Cells       Date:  2019-01-05       Impact factor: 6.600

Review 5.  Targeting the complexity of Src signalling in the tumour microenvironment of pancreatic cancer: from mechanism to therapy.

Authors:  Ashleigh Parkin; Jennifer Man; Paul Timpson; Marina Pajic
Journal:  FEBS J       Date:  2019-08-05       Impact factor: 5.542

6.  Promising xenograft animal model recapitulating the features of human pancreatic cancer.

Authors:  Jin-Xin Miao; Jian-Yao Wang; Hao-Ze Li; Hao-Ran Guo; Louisa S Chard Dunmall; Zhong-Xian Zhang; Zhen-Guo Cheng; Dong-Ling Gao; Jian-Zeng Dong; Zhong-De Wang; Yao-He Wang
Journal:  World J Gastroenterol       Date:  2020-08-28       Impact factor: 5.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.